Navigation Links
Med Discovery and Laborium Biopharma Extend Their Development Partnership to Include Mammalian Cell Culture Processes and Clinical Manufacturing for All Products in Med Discovery's Portfolio
Date:3/14/2009

Med Discovery SA, a specialized protein-based therapeutics oncology company, is proud to announce that they have extended their global partnership agreement with Laborium Biopharma, a subsidiary of Validapro BioSciences Inc. to encompass the cell culture process development and clinical manufacturing of all molecules under development at Med Discovery.

(PRWEB) March 14, 2009 -- Med Discovery SA, a specialized protein-based therapeutics oncology company, is proud to announce that they have extended their global partnership agreement with Laborium Biopharma, a subsidiary of Validapro BioSciences Inc. to encompass the cell culture process development and clinical manufacturing of all molecules under development at Med Discovery.

This strategic decision will allow Med Discovery SA to have priority access to Laborium Biopharma's clinical manufacturing capabilities and all related specialized services to ensure compliance of all its development projects to international regulations.

Dr. Deperthes President and CEO at Med Discovery S.A said: "In the upcoming months, Med Discovery will start the manufacturing of new biologics produced in mammalian cells. With this new extended agreement Med Discovery SA will accelerate the development of these innovative products allowing faster entry into pre-clinical and clinical phases. Validapro BioSciences Inc. will bring the operational flexibility and process development expertise to design value-added programs to meet Global cGMP expectations".

Luc Dubois President of Laborium Biopharma added: "In this difficult worldwide financial situation, such partnership agreement opens a new way to do business by sharing respective core competencies to reduce the risk associated with product development. That shall benefit both companies. Validapro BioSciences Inc. will be acting as the process development and clinical manufac
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

3

GOOD

Page: 1 2

Related biology technology :

1. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
2. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
3. European Centre for Modern Drug Discovery Established in Hamburg
4. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
5. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
6. Indivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug Development
7. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
8. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
9. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England
10. New method of selecting DNA for resequencing accelerates discovery of subtle DNA variations
11. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Med Discovery and Laborium Biopharma Extend Their Development Partnership to Include Mammalian Cell Culture Processes and Clinical Manufacturing for All Products in Med Discovery's Portfolio
(Date:5/21/2013)... Through science fairs, workshops, kits for building optical ... organizations will continue their work to increase awareness about ... daily life with the aid of SPIE Education ... countries, are the first of two groups of recipients ... international society for optics and photonics , in 2013. ...
(Date:5/21/2013)... , May 21, 2013 The ... and Transplant Association) is the biggest congress in ... therapy. Nearly 10,000 participants are in Istanbul ... latest research findings. New pioneering studies have been presented: ... FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES ESA USE" ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Smarter Security, ... security solutions, today announced that Genzyme, a Sanofi company ... of Door Detective® CL for a multi-use facility in ... in four other Genzyme buildings, this latest order underscores ... the tailgate detection device improving doorway access ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Many have ... as contributor to acne. Recently physicians from Clinical ... mental stress on the skin, and suggested using ... reduce the chemicals produced from stress that cause acne. ... the negative feelings acne brings about, stress causes changes ...
Breaking Biology Technology:Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2
... law in New Jersey could be sign of things ... about workplace violence,is nowhere more acute than among healthcare ... to become the target of on-the-job violence than,their counterparts ... of horrific headlines, healthcare facilities understandably face,mounting pressure to ...
... RICHMOND, Va., July 9 Insmed Inc. (Nasdaq:,INSM), a ... Glover, President Insmed Therapeutics, will present at the,Collins Stewart ... 10:30 AM ET, in New York., The conference ... New,York City, from Tuesday, July 8 through Thursday, July ...
... -- Dr. Fernando Perez-Ruiz Joins Ardea,s Inflammatory Disease Scientific ... ... Ardea Biosciences, Inc.,(Nasdaq: RDEA ) today announced that it has ... RDEA806 in gout,patients with hyperuricemia. Gout, also known as metabolic arthritis, ...
Cached Biology Technology:Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney 2Insmed to Present at Collins Stewart Fourth Annual Growth Conference 2Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout 2Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout 3Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout 4
(Date:5/17/2013)... 18, 2013) The AGA Research Foundation announced a ... relationship between the gut microbiota, one of today,s most ... , The AGA Research Awards Panel selected Andrew ... General Hospital and Harvard Medical School, Boston, as the ... Chan will receive $25,000 of funding, commencing in July ...
(Date:5/17/2013)... New Jersey, and City University of New York have ... that effectively clears organisms to be viewed under microscopes. ... which is one of the few high-quality clearing solutions ... Drug Enforcement Administration (DEA) due to its use as ... vital for viewing organisms under a microscope. Without them, ...
(Date:5/17/2013)... the interaction of a group of proteins in the ... identified a new target that could increase cell survival. ... School of Biochemistry and published in the EMBO ... eventually lead to new therapies for stroke and other ... by the team which identified a protein, known as ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3SUMO wrestling cells reveal new protective mechanism target for stroke 2
... Mycoplasma pneumoniae , which causes atypical pneumonia, is helping ... resources. By measuring all the proteins this bacterium produces, ... Heidelberg, Germany, and collaborators, have found that the secret ... a car after it has left the factory, cells ...
... Calif., and SHENZHEN, China, Feb. 28, 2012 ... announced a collaborative effort to develop methodologies designated ... assist scientists pursuing disease and drug research. ... a next-generation super exome, using Agilent,s SureSelect technology. ...
... 2012 Elsevier, a world-leading provider of scientific, ... that leading German scientist, Professor Dr. Manfred T. ... Hans Meerwein Research Professor at Philipps-Universitt, Marburg, has ... for Creativity in Organic Chemistry. The ...
Cached Biology News:Making the most of what you have 2Agilent Technologies and BGI to collaborate on next-generation super array 2Leading German Researcher awarded Elsevier's 2011 Tetrahedron Prize 2
... for whole-blood clinical diagnostic work in hospitals ... this analyzer makes precise glucose measurements of ... lactate measurements of whole blood, plasma, or ... allows you to have glucose results expressed ...
... Cleanroom-grade vinyl curtains or ... powder-coated steel support frame to ... cleanroom that meets cleanliness to ... HEPA filter/fan units, lights, and ...
... BioSafe room is configured specifically for ... chemical analysis. Panels are precision-joined to ... to wipe down and disinfect. One-inch ... panel design creates strong, rigid surface ...
... The Varian 500-MS LC Ion Trap ... high-throughput LC/MS analysis where sensitivity, reliability ... 500-MS provides a robust platform for ... mass resolution, and mass stability reflect ...
Biology Products: